Form 4: Roivant Sciences Director James C Momtazee Receives Stock Options and Restricted Stock Units

Director James C Momtazee received stock options and restricted stock units from Roivant Sciences Ltd. on September 10, 2024.

Summary

• James C Momtazee, a director of Roivant Sciences Ltd., received an annual award of 16,406 restricted stock units (RSUs) and 27,894 stock options on September 10, 2024.
• The RSUs and stock options were granted pursuant to the company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
• The RSUs will vest 100% on September 10, 2025, contingent upon continuous service.
• The stock options will also vest and become exercisable 100% on September 10, 2025, contingent upon continuous service.
• The exercise price of the stock options is $12.19.
• Following the transaction, Momtazee directly owns 95,490 common shares and 27,894 stock options.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for long-term commitment.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Risks

• The value of the RSUs and stock options is dependent on the future performance of Roivant Sciences' stock.
• The director must remain in continuous service to vest the awards.

Future Outlook

The director's compensation is tied to the future performance of the company's stock, incentivizing efforts to increase shareholder value.

Industry Context

Granting equity to directors is a common practice to align their interests with those of shareholders and incentivize long-term value creation. The specific terms of the grant (vesting schedule, exercise price) are typical for director compensation packages.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The vesting schedule of one year is fairly standard.
• The use of both stock options and restricted stock units is a common practice to provide both short-term and long-term incentives.

Stakeholder Impact

• Shareholders may view the equity grant positively as it aligns the director's interests with theirs.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates